Related references
Note: Only part of the references are listed.The origin of regulatory from the effector cells in LAG-3-marked Th1 immunity against severe influenza virus infection
Avijit Dutta et al.
IMMUNOLOGY (2023)
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
Federico Angriman et al.
LANCET RESPIRATORY MEDICINE (2021)
Relative COVID-19 Viral Persistence and Antibody Kinetics
Chung-Guei Huang et al.
PATHOGENS (2021)
Effectiveness of the Live Attenuated Influenza Vaccine: Was the Addition of the Second Type B Lineage a Step Too Far?
Arnold S. Monto
CLINICAL INFECTIOUS DISEASES (2020)
IL-17 stimulates the expression of CCL2 in cardiac myocytes via Act1/TRAF6/p38MAPK-dependent AP-1 activation
Shiyou Du et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
Salt generates antiinflammatory Th17 cells but amplifies pathogenicity in proinflammatory cytokine microenvironments
Julia Matthias et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza
Ching-Tai Huang et al.
PHYTOMEDICINE (2019)
IL-17A neutralizing antibody attenuates eosinophilic meningitis caused by Angiostrongylus cantonensis by involving IL-17RA/Traf6/NF-κB signaling
Ying Feng et al.
EXPERIMENTAL CELL RESEARCH (2019)
IL-17 receptor-based signaling and implications for disease
Xiaoxia Li et al.
NATURE IMMUNOLOGY (2019)
IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
Xing Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
Yue-Nan Ni et al.
CRITICAL CARE (2019)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation
Reiko Matsumoto et al.
JCI INSIGHT (2018)
New fronts emerge in the influenza cytokine storm
Xi-zhi J. Guo et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model
Ching-Tai Huang et al.
SCIENTIFIC REPORTS (2017)
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
William J. Liu et al.
ANTIVIRAL RESEARCH (2017)
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia
Bin Cao et al.
CRITICAL CARE MEDICINE (2016)
Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs
Avijit Dutta et al.
SCIENTIFIC REPORTS (2016)
A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis
Ling Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection
Avijit Dutta et al.
NATURE COMMUNICATIONS (2015)
Altered T-bet Dominance in IFN-γ-Decoupled CD4+ T Cells with Attenuated Cytokine Storm and Preserved Memory in Influenza
Avijit Dutta et al.
JOURNAL OF IMMUNOLOGY (2013)
Interleukin-17 and a tale of two autoimmune diseases
Dominique L. P. Baeten et al.
NATURE MEDICINE (2013)
IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus
Chenggang Li et al.
CELL RESEARCH (2012)
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes
Jarod A. Zepp et al.
JOURNAL OF IMMUNOLOGY (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Induction and molecular signature of pathogenic TH17 cells
Youjin Lee et al.
NATURE IMMUNOLOGY (2012)
T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR gamma t
Vanja Lazarevic et al.
NATURE IMMUNOLOGY (2011)
Anti-Inflammatory Role of IL-17 in Experimental Autoimmune Uveitis
Yan Ke et al.
JOURNAL OF IMMUNOLOGY (2009)
Thymic output in aged mice
J. Scott Hale et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
The influence of age on T cell generation and TCR diversity
K Naylor et al.
JOURNAL OF IMMUNOLOGY (2005)
T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3
ES Hwang et al.
SCIENCE (2005)
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance
YP Yang et al.
NATURE IMMUNOLOGY (2004)
CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction
CT Huang et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumor necrosis factor receptor-associated factors (TRAFs)
JR Bradley et al.
ONCOGENE (2001)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
Share Paper
